Cathy M. Holt

1.6k total citations
39 papers, 1.3k citations indexed

About

Cathy M. Holt is a scholar working on Surgery, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Cathy M. Holt has authored 39 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 14 papers in Molecular Biology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Cathy M. Holt's work include Coronary Interventions and Diagnostics (9 papers), Electrospun Nanofibers in Biomedical Applications (5 papers) and Tissue Engineering and Regenerative Medicine (4 papers). Cathy M. Holt is often cited by papers focused on Coronary Interventions and Diagnostics (9 papers), Electrospun Nanofibers in Biomedical Applications (5 papers) and Tissue Engineering and Regenerative Medicine (4 papers). Cathy M. Holt collaborates with scholars based in United Kingdom, Switzerland and Denmark. Cathy M. Holt's co-authors include Sheila Francis, Hazel M. Holden, Johanna Armstrong, Joseph Galea, D.C. Cumberland, David C. Crossman, L Shepherd, Gordon W. Duff, Julian Gunn and Andrew L. Lewis and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Biomaterials.

In The Last Decade

Cathy M. Holt

38 papers receiving 1.3k citations

Peers

Countries citing papers authored by Cathy M. Holt

Since Specialization

Citations

This map shows the geographic impact of Cathy M. Holt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathy M. Holt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathy M. Holt more than expected).

Fields of papers citing papers by Cathy M. Holt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathy M. Holt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathy M. Holt. The network helps show where Cathy M. Holt may publish in the future.

Co-authorship network of co-authors of Cathy M. Holt

This figure shows the co-authorship network connecting the top 25 collaborators of Cathy M. Holt. A scholar is included among the top collaborators of Cathy M. Holt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathy M. Holt. Cathy M. Holt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Small diameter helical vascular scaffolds support endothelial cell survival 2018 ·Nanomedicine Nanotechnology Biology and Medicine ·(unknown), Juned Kadiwala, Araida Hidalgo‐Bastida, Cathy M. Holt, Mohammad Sanami, Mohsen Miraftab, Rameen Shakur, May Azzawi	15
2	Selective improvement of pulmonary arterial hypertension with a dual ET_A/ET_Breceptors antagonist in the apolipoprotein E^−/−model of PAH and atherosclerosis 2017 ·Pulmonary Circulation ·Lewis Renshall, Nadine Arnold, Laura West, Adam Braithwaite, Josephine Pickworth, Rachel Walker, Mabruka Alfaidi, Janet Chamberlain, Helen Casbolt, A. A. Roger Thompson, Cathy M. Holt, Marc Iglarz, Sheila Francis, Allan Lawrie	9
3	Combined MSC and GLP‐1 Therapy Modulates Collagen Remodeling and Apoptosis following Myocardial Infarction 2016 ·Stem Cells International ·Elizabeth J. Wright, Nigel W. Hodson, Michael J. Sherratt, Moustapha Kassem, Andrew L. Lewis, Christine Wallrapp, (unknown), Cathy M. Holt	18
4	Serum cholesterol selectively regulates glucocorticoid sensitivity through activation of JNK 2014 ·Journal of Endocrinology ·Nan Yang, Giorgio Caratti, Louise M. Ince, Toryn Poolman, (unknown), Cathy M. Holt, David Ray, Laura Matthews	9
5	Controlled delivery of antisense oligonucleotides: a brief review of current strategies 2009 ·Expert Opinion on Drug Delivery ·Xiubo Zhao, Fang Pan, Cathy M. Holt, Andrew L. Lewis, Jian R. Lu	69
6	Controlled delivery of anti-sense oligodeoxynucleotide from multilayered biocompatible phosphorylcholine polymer films 2008 ·Journal of Controlled Release ·(unknown), Xichuan Cao, Xiubo Zhao, Cathy M. Holt, Andrew L. Lewis, Jian R. Lu	13
7	Notch3 activation modulates cell growth behaviour and cross-talk to Wnt/TCF signalling pathway 2007 ·Cellular Signalling ·Tao Wang, Cathy M. Holt, (unknown), Caroline Ridley, Richard Jones, Martín Baron, Dorothy Trump	41
8	Vascular delivery of c-myc antisense from cationically modified phosphorylcholine coated stents 2006 ·Biomaterials ·(unknown), Johanna Armstrong, Sarah Withers, (unknown), D.C. Cumberland, Julian Gunn, Cathy M. Holt	16
9	VP22‐mediated intercellular transport correlates with enhanced biological activity of MybEngrailed but not (HSV‐I) thymidine kinase fusion proteins in primary vascular cells following non‐viral transfection 2004 ·The Journal of Gene Medicine ·Paul Sheridan, Allan Lawrie, David C. Crossman, Cathy M. Holt, Christopher Newman	4
10	Phosphorylcholine-coated stents in porcine coronary arteries: in vivo assessment of biocompatibility. 2001 ·PubMed ·(unknown), Jarmo Gunn, L Shepherd, David C. Crossman, D.C. Cumberland, Cathy M. Holt	40
11	Apoptosis and cell proliferation following porcine coronary angioplasty 1998 ·Research Explorer (The University of Manchester) ·(unknown), Sheila Francis, Cathy M. Holt, Jarmo Gunn, (unknown), L Shepherd, Janet Chamberlain, (unknown), (unknown), DC Crossman	1
12	Interleukin-1 in Myocardium and Coronary Arteries of Patients with Dilated Cardiomyopathy 1998 ·Journal of Molecular and Cellular Cardiology ·Sheila Francis, Hazel M. Holden, Cathy M. Holt, Gordon W. Duff	110
13	Intravascular stents: a new technique for tissue processing for histology, immunohistochemistry, and transmission electron microscopy 1998 ·Heart ·(unknown), Julian Gunn, Cathy M. Holt, L Shepherd, Sheila Francis, Christopher Newman, David C. Crossman, D.C. Cumberland	50
14	The Effect of Oligonucleotides to c -myb on Vascular Smooth Muscle Cell Proliferation and Neointima Formation After Porcine Coronary Angioplasty 1997 ·Circulation Research ·Julian Gunn, Cathy M. Holt, Sheila Francis, L Shepherd, M. Grohmann, Christopher M. Newman, David C. Crossman, D.C. Cumberland	50
15	Release of platelet derived growth factor in serum-free organ culture of human coronary artery 1994 ·Cardiovascular Research ·Cathy M. Holt, Sheila Francis, (unknown), (unknown), Mohammad Bashar Izzat, Gianni D. Angelini	7
16	Comparison of response to injury in organ culture of human saphenous vein and internal mammary artery 1993 ·The Annals of Thoracic Surgery ·Cathy M. Holt, Sheila Francis, Andrew C. Newby, S. Rogers, (unknown), (unknown), Gianni D. Angelini	50
17	Intimal proliferation in an organ culture of human internal mammary artery 1992 ·Cardiovascular Research ·Cathy M. Holt, Sheila Francis, S. Rogers, (unknown), (unknown), Colin Clelland, Abigail A. Soyombo, A.C. Newby, Gianni D. Angelini	32
18	PROSTACYCLIN PRODUCTION BY HUMAN UMBILICAL VEIN ENDOTHELIUM IN RESPONSE TO SERUM FROM PATIENTS WITH SYSTEMIC SCLEROSIS 1989 ·Lara D. Veeken ·Cathy M. Holt, (unknown), Nigel J. Lindsey, Patrick Hughes, M. Greaves, N.R. Rowell	3
19	ELEVATED von WILLEBRAND FACTOR ANTIGEN IN SYSTEMIC SCLEROSIS: RELATIONSHIP TO VISCERAL DISEASE 1988 ·Lara D. Veeken ·M. Greaves, R G Malía, A. Milford Ward, (unknown), Cathy M. Holt, Nigel J. Lindsey, Pamela Hughes, (unknown), N.R. Rowell	37
20	Anticardiolipin antibodies in systemic sclerosis: immunological and clinical associations. 1988 ·PubMed ·R G Malía, M. Greaves, (unknown), Alexandra Lawrence, (unknown), N.R. Rowell, (unknown), Cathy M. Holt, Nigel J. Lindsey, Pamela Hughes	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact